Dexamethasone Dose for COVID‐19 in a Large U.S. Hospital Network From April 2020 to May 2023

ABSTRACT Purpose While potential harm from high doses of systemic dexamethasone for clinical management of COVID‐19 is an important concern, little is known about real world dexamethasone dosing in patients hospitalized with COVID‐19 in the United States. Methods Descriptive study to assess dexameth...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacoepidemiology and drug safety 2024-10, Vol.33 (10), p.e70018-n/a
Hauptverfasser:	Bradley, Marie C., Rai, Ashish, Cosgrove, Austin, Perez‐Vilar, Silvia, Fuller, Candace, Rosen, Edward, Eworuke, Efe, McLean, Laura E., Guy, Jeffrey S., Poland, Russell E., Sands, Kenneth E., Dal Pan, Gerald J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged COVID-19 COVID-19 - epidemiology COVID-19 Drug Treatment Dexamethasone Dexamethasone - administration & dosage Dexamethasone - adverse effects Dexamethasone - therapeutic use Dosage Dose-Response Relationship, Drug drug safety electronic medical records epidemiology Female Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Glucocorticoids - therapeutic use Hospitalization Hospitalization - statistics & numerical data Humans Male Middle Aged Oxygen SARS-CoV-2 United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!